Since its IPO on the Paris stock exchange in 1997, Eurofins’ revenues have increased by 32% each year (in compound average) to reach EUR 6.95 billion revenues for FY 2024.

Between the Initial Public Offering on 24 October 1997 (€0.183) and 31 December 2024 (€49.31), Eurofins’ share price has multiplied by 269x, an annual average increase of 23%.

Over our 37-year history, we’ve expanded from one laboratory in Nantes, France, to over 950 laboratories in over 1,000 independent companies across 60 countries. 

We perform more than 450 million tests per year and offer over 200,000 analytical methods, working for the world’s leading food retailers, food producers and pharmaceutical companies.